Optogenetics in chronic neurodegenerative diseases, controlling the brain with light: A systematic review
Journal of Neuroscience Research · 2024
DOI: 10.1002/jnr.25321 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Neuroscience Research, 2024. Verfasst von Rojine El Hajj und 2 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon. Hauptthemen laut MEDLINE: Optogenetics, Neurodegenerative Diseases, Brain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 115 Literaturangaben.
Abstract (Originalsprache)
Neurodegenerative diseases are progressive disorders characterized by synaptic loss and neuronal death. Optogenetics combines optical and genetic methods to control the activity of specific cell types. The efficacy of this approach in neurodegenerative diseases has been investigated in many reviews, however, none of them tackled it systematically. Our study aimed to review systematically the findings of optogenetics and its potential applications in animal models of chronic neurodegenerative diseases and compare it with deep brain stimulation and designer receptors exclusively activated by designer drugs techniques. The search strategy was performed based on the PRISMA guidelines and the risk of bias was assessed following the Systematic Review Centre for Laboratory Animal Experimentation tool. A total of 247 articles were found, of which 53 were suitable for the qualitative analysis. Our data revealed that optogenetic manipulation of distinct neurons in the brain is efficient in rescuing memory impairment, alleviating neuroinflammation, and reducing plaque pathology in Alzheimer's disease. Similarly, this technique shows an advanced understanding of the contribution of various neurons involved in the basal ganglia pathways with Parkinson's disease motor symptoms and pathology. However, the optogenetic application using animal models of Huntington's disease, multiple sclerosis, and amyotrophic lateral sclerosis was limited. Optogenetics is a promising technique that enhanced our knowledge in the research of neurodegenerative diseases and addressed potential therapeutic solutions for managing these diseases' symptoms and delaying their progression. Nevertheless, advanced investigations should be considered to improve optogenetic tools' efficacy and safety to pave the way for their translatability to the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
ORCID-Profile: Nissrine Ballout
Zitieren
APA
El Hajj, R., Al Sagheer, T., & Ballout, N. (2024). Optogenetics in chronic neurodegenerative diseases, controlling the brain with light: A systematic review. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.25321
Vancouver
El Hajj R, Al Sagheer T, Ballout N. Optogenetics in chronic neurodegenerative diseases, controlling the brain with light: A systematic review. Journal of Neuroscience Research. 2024. doi:10.1002/jnr.25321
BibTeX
@article{ElHajj2024,
author = {El Hajj, Rojine and Al Sagheer, Tareq and Ballout, Nissrine},
title = {Optogenetics in chronic neurodegenerative diseases, controlling the brain with light: A systematic review},
journal = {Journal of Neuroscience Research},
year = {2024},
doi = {10.1002/jnr.25321}
}
EUVIMED